Search results
Showing 1 to 3 of 3 results for metreleptin
Evidence-based recommendations on metreleptin (Myalepta) for treating lipodystrophy in children and adults.
Past technology appraisal appeals and decisions
This document describes a real-world evidence framework that aims to improve the quality of real-world evidence informing our guidance. The framework does not set minimum standards for the acceptability of evidence. The framework is mainly targeted at those developing evidence to inform NICE guidance. It is also relevant to patients, those collecting data, and reviewers of evidence